Skip to main content
SpringerLink
Log in

Enucleation for Ocular Tumors

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

  • 1075 Accesses

Abstract

Many studies over the past decade report a trend toward fewer enucleations, suggesting that improved treatments prevent end-stage eye disease. Interestingly, however, the incidence of enucleation for neoplasia has not decreased despite the more widespread use of globe-sparing techniques, such as chemotherapy and brachytherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Setlur VJ, Parikh JG, Rao NA. Changing causes of enucleation over the past 60 years. Graefes Arch Clin Exp Ophthalmol. 2010;248(4):593–7.

    Article  PubMed  Google Scholar 

  2. Melia M, Moy CS, Reynolds SM, Hayman JA, Murray TG, Hovland KR, Earle JD, Kurinij N, Dong LM, Miskala PH, et al. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS report no. 3. Arch Ophthalmol. 2006;124(2):226–38.

    Article  PubMed  Google Scholar 

  3. Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, Diddie KR, Engstrom Jr RE, Finger PT, Hovland KR, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology. 2002;109(12):2197–206.

    Article  PubMed  Google Scholar 

  4. Fine SL, Hawkins BS. The investigators’ perspective on the collaborative ocular melanoma study. Arch Ophthalmol. 2007;125(7):968–71.

    Article  PubMed  Google Scholar 

  5. De Potter P, Shields JA, Shields CL, Santos R. Modified enucleation via lateral orbitotomy for choroidal melanoma with orbital extension: a report of two cases. Ophthal Plast Reconstr Surg. 1992;8(2):109–13.

    Article  PubMed  Google Scholar 

  6. Fusetti S, Parrozzani R, Urban F, Gurabardhi M, Ferronato G, Midena E. Modified enucleation for choroidal melanoma with large extrascleral extension. Orbit. 2010;29(2):70–5.

    Article  PubMed  Google Scholar 

  7. Singh AD, Jacques R, Rundle PA, Mudhar HS, Rennie IG. Combined enucleation and orbitotomy for choroidal melanoma with orbital extension. Eye (Lond). 2006;20(5):615–7.

    Article  CAS  Google Scholar 

  8. Blanco G. Diagnosis and treatment of orbital invasion in uveal melanoma. Can J Ophthalmol. 2004;39(4):388–96.

    PubMed  Google Scholar 

  9. Moshfeghi DM, Moshfeghi AA, Finger PT. Enucleation. Surv Ophthalmol. 2000;44(4):277–301.

    Article  PubMed  CAS  Google Scholar 

  10. Amaro TA, Yazigi L, Erwenne C. Depression and quality of life during treatment of ocular bulb removal in individuals with uveal melanoma. Eur J Cancer Care (Engl). 2010;19(4):476–81.

    Article  CAS  Google Scholar 

  11. Coday MP, Warner MA, Jahrling KV, Rubin PA. Acquired monocular vision: functional consequences from the patient’s perspective. Ophthal Plast Reconstr Surg. 2002;18(1):56–63.

    Article  PubMed  Google Scholar 

  12. Yen KG, Elner VM, Musch DC, Nelson CC. Periocular versus general anesthesia for ocular enucleation. Ophthal Plast Reconstr Surg. 2008;24(1):24–8.

    Article  PubMed  Google Scholar 

  13. Gayre GS, Lipham W, Dutton JJ. A comparison of rates of fibrovascular ingrowth in wrapped versus unwrapped hydroxyapatite spheres in a rabbit model. Ophthal Plast Reconstr Surg. 2002;18(4):275–80.

    Article  PubMed  Google Scholar 

  14. Viswanathan P, Sagoo MS, Olver JM. UK national survey of enucleation, evisceration and orbital implant trends. Br J Ophthalmol. 2007;91(5):616–9.

    Article  PubMed  CAS  Google Scholar 

  15. Custer PL, Kennedy RH, Woog JJ, Kaltreider SA, Meyer DR. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2003;110(10):2054–61.

    Article  PubMed  Google Scholar 

  16. Colen TP, Paridaens DA, Lemij HG, Mourits MP, van Den Bosch WA. Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology. 2000;107(10):1889–94.

    Article  PubMed  CAS  Google Scholar 

  17. Perry JD, Tam RC. Safety of unwrapped spherical orbital implants. Ophthal Plast Reconstr Surg. 2004;20(4):281–4.

    Article  PubMed  Google Scholar 

  18. Wells TS, Harris GJ. Direct fixation of extraocular muscles to a silicone sphere: a cost-sensitive, low-risk enucleation procedure. Ophthal Plast Reconstr Surg. 2011;27(5):364–7.

    Article  PubMed  Google Scholar 

  19. Kaltreider SA, Lucarelli MJ. A simple algorithm for selection of implant size for enucleation and evisceration: a prospective study. Ophthal Plast Reconstr Surg. 2002;18(5):336–41.

    Article  PubMed  Google Scholar 

  20. Kaltreider SA, Peake LR, Carter BT. Pediatric enucleation: analysis of volume replacement. Arch Ophthalmol. 2001;119(3):379–84.

    Article  PubMed  CAS  Google Scholar 

  21. Perry JD, Singh AD, Mehta MP. Enucleation for choroidal melanomas. In: Ryan SJ, editor. Retina. St. Louis: Elsevier; 2011.

    Google Scholar 

  22. Shields JA, Augsburger JJ, Dougherty MJ. Orbital recurrence of choroidal melanoma 20 years after enucleation. Am J Ophthalmol. 1984;97(6):767–70.

    PubMed  CAS  Google Scholar 

  23. Asensio Sanchez VM, Alonso M, Sierra JM. Positron emission tomography in the diagnosis of orbital relapse of choroidal melanoma. Arch Soc Esp Oftalmol. 2005;80(2):113–5.

    PubMed  CAS  Google Scholar 

  24. Tataru CP, Pop MD. Enucleation in malignant choroidal melanoma – results in 15 years of using a new material in the prosthesis of the orbital cavity. J Med Life. 2012;5(2):185–8.

    PubMed  CAS  Google Scholar 

  25. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11. Am J Ophthalmol. 1998;126(3):362–72.

    Google Scholar 

  26. Sami D, Young S, Petersen R. Perspective on orbital enucleation implants. Surv Ophthalmol. 2007;52(3):244–65.

    Article  PubMed  Google Scholar 

  27. Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg. 2004;20(4):274–80.

    Article  PubMed  Google Scholar 

  28. Nunery WR, Heinz GW, Bonnin JM, Martin RT, Cepela MA. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg. 1993;9(2):96–104.

    Article  PubMed  CAS  Google Scholar 

  29. Nunery WR, Cepela MA, Heinz GW, Zale D, Martin RT. Extrusion rate of silicone spherical anophthalmic socket implants. Ophthal Plast Reconstr Surg. 1993;9(2):90–5.

    Article  PubMed  CAS  Google Scholar 

  30. Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthal Plast Reconstr Surg. 2007;23(1):1–7.

    Article  PubMed  Google Scholar 

  31. Rasmussen ML. The eye amputated - consequences of eye amputation with emphasis on clinical aspects, phantom eye syndrome and quality of life. Acta Ophthalmol. 2010;88 Thesis 2:1–26.

    Google Scholar 

  32. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21(3):203–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Natta Sakolsatayadorn MD

  2. Division of Ophthalmology, Cole Eye Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Julian D. Perry MD

Authors
  1. Natta Sakolsatayadorn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julian D. Perry MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julian D. Perry MD .

Editor information

Editors and Affiliations

  1. Division of Opthalmology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Julian D. Perry

  2. Department of Ophthalmic Oncology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Arun D. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sakolsatayadorn, N., Perry, J.D. (2014). Enucleation for Ocular Tumors. In: Perry, J., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40492-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40492-4_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40491-7

  • Online ISBN: 978-3-642-40492-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation